What is the current Haematology Analyser market size?

The Haematology Analyser market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Haematology Analyser market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Haematology Analyser market?

Increasing demand for diagnostic tests and advancements in technology are key drivers.

What are the major challenges facing the Haematology Analyser market?

High costs and limited accessibility in developing regions are major challenges.

Which regions are leading the Haematology Analyser market?

North America and Europe are currently leading the Haematology Analyser market.

Who are the top companies in the Haematology Analyser market?

Top companies include Siemens, Beckman Coulter, and Abbott Laboratories.

What are the future opportunities in the Haematology Analyser market?

Emerging markets and technological advancements offer future opportunities.

How is technology impacting the Haematology Analyser market?

Advances in automation and data analysis are significantly impacting the market.

What is the current regulatory landscape for the Haematology Analyser market?

The market is regulated by agencies such as the FDA and CE marking.

What is the future outlook for the Haematology Analyser market?

The future outlook is positive with increasing demand for diagnostic tests.

Haematology Analyser Market Intelligence Report 2026 — Updated June 2026

Haematology Analyser by Application (Hospital, Laboratory), by Types (Automatic Hematology Analyzers, Semiautomatic Hematology Analyzers), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 134

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 134

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Haematology Analyser Market Overview

The Haematology Analyser market refers to the industry that produces and distributes devices used to analyze blood samples. As a crucial component of medical diagnostics, the Haematology Analyser market size is estimated to be around $1.4 billion. The growth outlook for the Haematology Analyser market forecast is promising, with an expected compound annual growth rate (CAGR) of 5.5% from 2026 to 2033, driven by factors such as an aging population, an increase in blood-related disorders, and advancements in technology. The industry expansion is anticipated to be significant, with key drivers including the rising demand for automated haematology analysers, the growing need for accurate and efficient diagnostic results, and the increasing adoption of point-of-care testing. The scope of the Haematology Analyser market encompasses various types of analysers, including automated, semi-automated, and manual devices, as well as different applications, such as clinical diagnostics, research, and blood banking.

Loading chart…

The Haematology Analyser market is shaped by several key forces, including technological advancements, regulatory requirements, and changing consumer behavior. The largest region in the Haematology Analyser market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing demand for medical diagnostics and the growing healthcare infrastructure. The market is expected to witness significant growth in the coming years, driven by the rising demand for accurate and efficient diagnostic results, and the increasing adoption of automated haematology analysers. Overall, the Haematology Analyser market is poised for significant growth and expansion, driven by technological advancements, regulatory requirements, and changing consumer behavior.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sysmex Corporation; Beckman Coulter, Inc.; Abbott Laboratories; Siemens Healthcare; HORIBA ABX SAS; Mindray; Bio-Rad Laboratories; Nihon Kohden; Abaxis
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Haematology Analyser market is witnessing significant growth, driven by various factors. The market dynamics are influenced by several key elements that are shaping the industry's trajectory.

Growth Drivers2 items

Advances in technology, such as automation and artificial intelligence, are enhancing the efficiency and accuracy of Haematology Analysers, driving their adoption in laboratories and hospitals, and subsequently contributing to the growth of the Haematology Analyser market size.

The increasing prevalence of blood disorders and diseases, such as anaemia and leukaemia, is fueling the demand for Haematology Analysers, thereby supporting the growth forecast of the Haematology Analyser market.

Restraints2 items

The high cost of Haematology Analysers, particularly the advanced models, is limiting their adoption in resource-constrained settings, such as small laboratories and hospitals in developing countries, which can hinder the growth of the Haematology Analyser market.

The shortage of skilled professionals to operate and maintain Haematology Analysers is a significant restraint, as it can lead to inaccurate results and reduced efficiency, ultimately affecting the Haematology Analyser market size.

Opportunities2 items

The increasing focus on point-of-care testing and decentralization of laboratory services is creating new opportunities for the Haematology Analyser market, as manufacturers develop portable and user-friendly devices for use in clinics and physician offices.

The rising demand for personalized medicine and targeted therapies is driving the need for advanced Haematology Analysers that can provide detailed and accurate results, supporting the growth forecast of the Haematology Analyser market.

Challenges2 items

The Haematology Analyser market is highly competitive, with several established players competing for market share, making it challenging for new entrants to establish themselves and for existing manufacturers to maintain their position.

The regulatory landscape for Haematology Analysers is evolving, with increasing emphasis on quality control and safety standards, which can pose challenges for manufacturers in terms of compliance and certification, affecting the overall Haematology Analyser market size.

Market Segmentation

Loading chart…

The Haematology Analyser market can be segmented based on Application, which includes various subtypes such as diagnostic laboratories, research institutions, and hospitals. This segmentation category contributes to the overall Haematology Analyser market size by highlighting the specific areas where these analysers are used. Understanding the application segment is crucial for market players to develop targeted strategies and products that cater to the needs of different end-users. The Haematology Analyser segmentation by application provides valuable insights into the market taxonomy and helps in identifying potential growth opportunities.

Another significant segmentation category in the Haematology Analyser market is Types, which includes subtypes such as fully automated analysers, semi-automated analysers, and manual analysers. This segment plays a vital role in determining the overall market size as it reflects the technological advancements and innovations in the field of haematology analysis. The types segment is essential for market players to understand the current trends and preferences of end-users, enabling them to develop and launch products that meet the evolving demands of the market. By analysing the Haematology Analyser market taxonomy, industry stakeholders can gain a deeper understanding of the competitive landscape and make informed decisions to stay ahead in the market.

Haematology Analyser Segmentation Breakdown6 items

Application

Hospital

Laboratory

Types

Automatic Hematology Analyzers

Semiautomatic Hematology Analyzers

Regional Insights

Loading chart…

The Haematology Analyser market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of automated haematology analysers, favourable policies, and significant investments in healthcare infrastructure.

In North America, key drivers include a mature ecosystem, high adoption rates of advanced haematology analysers, and a strong focus on research and development. Europe is driven by a large demographics of aging population, established infrastructure, and stringent regulations promoting the use of haematology analysers. Asia Pacific's growth is fueled by increasing investments in healthcare, rising awareness about haematological disorders, and expanding distribution networks. Latin America's growth is driven by improving infrastructure, growing demand for haematology testing, and government initiatives to enhance healthcare services. The Middle East & Africa region is expected to grow due to increasing adoption of haematology analysers, partnerships between local healthcare providers and international companies, and rising healthcare expenditure.

Regional Forecast5 items

North America: 35% market share, driven by mature ecosystem and high adoption rates

Europe: 25% market share, driven by large demographics and established infrastructure

Asia Pacific: 20% market share, driven by increasing investments and rising awareness

Latin America: 10% market share, driven by improving infrastructure and growing demand

Middle East & Africa: 10% market share, driven by increasing adoption and partnerships

Competitive Landscape

The Haematology Analyser market is moderately consolidated, with a mix of global players and local companies competing for market share. The Haematology Analyser competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to dominate the market, but local companies are gaining traction through strategic partnerships and localized product offerings.

Companies in the market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies are notable for their strategic focus:

Sysmex Corporation: regional expansion

Beckman Coulter, Inc.: innovation pipeline

Abbott Laboratories: premium pricing

Siemens Healthcare: vertical integration

HORIBA ABX SAS: local manufacturing

Mindray: OEM tie-ups

Key Haematology Analyser Companies9 items

Sysmex Corporation

Beckman Coulter, Inc.

Abbott Laboratories

Siemens Healthcare

HORIBA ABX SAS

Mindray

Bio-Rad Laboratories

Nihon Kohden

Abaxis

Market Ecosystem

The Haematology Analyser ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. Value is created and captured through the development, manufacturing, and distribution of haematology analysers, as well as the provision of related services and support. The ecosystem can be broadly segmented into three key stages: upstream, where raw materials and components are sourced; midstream, where analysers are manufactured and integrated; and downstream, where products are distributed and used by end users.

Raw material/component suppliers — provide critical components

OEMs / manufacturers — design and manufacture haematology analysers

System integrators / EPCs — integrate analysers into larger systems

Distributors / channel partners — distribute products to end users

Service providers / after-sales — offer maintenance and support services

End users / buyers — purchase and use haematology analysers

Regulators/standards bodies — establish standards and guidelines

In the Haematology Analyser ecosystem, control points lie with regulators, who influence adoption through standards and approvals, and with end users, who drive demand through purchasing decisions. Dependency risks arise from input constraints, such as component shortages, and from regulatory requirements, which can impact product development and distribution. Switching costs and partnerships also play a crucial role, as manufacturers and distributors form relationships to ensure seamless integration and support. Furthermore, the ecosystem differs by region, with varying regulatory requirements and market conditions influencing the value chain analysis and the flow of value through the Haematology Analyser ecosystem.

Recent Industry Insights

The Haematology Analyser industry has witnessed significant developments over the last 12-18 months, shaping the Haematology Analyser industry trends. Recent partnerships between leading manufacturers and research institutions have focused on developing innovative diagnostic solutions. Notable mergers and acquisitions have also taken place, with major players expanding their product portfolios and strengthening their market presence.

Furthermore, several product launches have introduced advanced technologies, such as artificial intelligence and machine learning, to improve the accuracy and efficiency of haematology analysis. Regulatory changes have also influenced the industry, with updated guidelines for the development and approval of haematology analysers. These developments have contributed to a shift in consumer and enterprise trends, with a growing emphasis on personalized medicine and point-of-care testing.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Haematology Analyser market. The Haematology Analyser market outlook is promising, driven by increasing demand for diagnostic testing and technological advancements. The market attractiveness is high, with a growing need for accurate and efficient haematology analysis. Competitive intensity is moderate, with key players investing in research and development to improve product offerings.

The long-term outlook is positive, with opportunities for innovation and expansion into emerging markets. The innovation landscape is evolving, with a focus on automated and portable haematology analysers. Demand-supply balance is expected to be stable, with key risk factors including regulatory changes and intense competition. Overall, the Haematology Analyser market presents opportunities for growth and investment, driven by advancing technology and increasing demand for diagnostic testing.

12 items

1. Executive Summary

2. Haematology Analyser Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Haematology Analyser Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Haematology Analyser Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Haematology Analyser Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Haematology Analyser Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Haematology Analyser Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Haematology Analyser Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Haematology Analyser Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Haematology Analyser Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Haematology Analyser Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Haematology Analyser Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Haematology Analyser Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Haematology Analyser Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Haematology Analyser Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Haematology Analyser Market Competition by Key Manufacturers

9.1. Global Haematology Analyser Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Haematology Analyser: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sysmex Corporation

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Beckman Coulter, Inc.

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Abbott Laboratories

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Siemens Healthcare

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. HORIBA ABX SAS

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Mindray

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Bio-Rad Laboratories

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Nihon Kohden

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Abaxis

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Haematology Analyser Market

Figure 4: Global Haematology Analyser Market: Drivers

Figure 5: Global Haematology Analyser Market: Challenges

Figure 6: Global Haematology Analyser Market: Trends

Figure 7: Global Haematology Analyser Market: Opportunity

Figure 8: Global Haematology Analyser Market: Restraint

Figure 9: Global Haematology Analyser Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Haematology Analyser Market Value (USD Million) By Region

Figure 19: Global Haematology Analyser Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Haematology Analyser Market Value (USD Million) By Region

Figure 27: Global Haematology Analyser Market Share (%) By: Regions (2032)

Figure 28: Global Haematology Analyser Market Volume (K) By Region

Figure 29: Global Haematology Analyser Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Haematology Analyser Market Value (USD Million) By Region

Figure 37: Global Haematology Analyser Market Share (%) By: Regions (2032)

Figure 38: Global Haematology Analyser Market Volume (K) By Region

Figure 39: Global Haematology Analyser Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Haematology Analyser Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Haematology Analyser Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Haematology Analyser Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Haematology Analyser Market Value (USD Million) By Region

Table 14: Global Haematology Analyser Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Haematology Analyser Market Volume (K) By Region

Table 31: Global Haematology Analyser Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Haematology Analyser Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Haematology Analyser Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Haematology Analyser Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sysmex Corporation Basic Information And Sales Area

Table 52: Sysmex Corporation. Products Portfolio

Table 53: Beckman Coulter, Inc. Basic Information And Sales Area

Table 54: Beckman Coulter, Inc.. Products Portfolio

Table 55: Abbott Laboratories Basic Information And Sales Area

Table 56: Abbott Laboratories. Products Portfolio

Table 57: Siemens Healthcare Basic Information And Sales Area

Table 58: Siemens Healthcare. Products Portfolio

Table 59: HORIBA ABX SAS Basic Information And Sales Area

Table 60: HORIBA ABX SAS. Products Portfolio

Table 61: Mindray Basic Information And Sales Area

Table 62: Mindray. Products Portfolio

Table 63: Bio-Rad Laboratories Basic Information And Sales Area

Table 64: Bio-Rad Laboratories. Products Portfolio

Table 65: Nihon Kohden Basic Information And Sales Area

Table 66: Nihon Kohden. Products Portfolio

Table 67: Abaxis Basic Information And Sales Area

Table 68: Abaxis. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Haematology Analyser Market Value (USD Million) By Region

Table 78: Global Haematology Analyser Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global Haematology Analyser Market Volume (K) By Region

Table 95: Global Haematology Analyser Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Haematology Analyser Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sysmex Corporation; Beckman Coulter, Inc.; Abbott Laboratories; Siemens Healthcare; HORIBA ABX SAS; Mindray; Bio-Rad Laboratories; Nihon Kohden; Abaxis
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Haematology Analyser market is witnessing significant growth, driven by various factors. The market dynamics are influenced by several key elements that are shaping the industry's trajectory.

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Haematology Analyser Segmentation Breakdown6 items

Application

Hospital

Laboratory

Types

Automatic Hematology Analyzers

Semiautomatic Hematology Analyzers

Regional Insights

Loading chart…

Regional Forecast5 items

North America: 35% market share, driven by mature ecosystem and high adoption rates

Europe: 25% market share, driven by large demographics and established infrastructure

Asia Pacific: 20% market share, driven by increasing investments and rising awareness

Latin America: 10% market share, driven by improving infrastructure and growing demand

Middle East & Africa: 10% market share, driven by increasing adoption and partnerships

Competitive Landscape

Sysmex Corporation: regional expansion

Beckman Coulter, Inc.: innovation pipeline

Abbott Laboratories: premium pricing

Siemens Healthcare: vertical integration

HORIBA ABX SAS: local manufacturing

Mindray: OEM tie-ups

Key Haematology Analyser Companies9 items

Sysmex Corporation

Beckman Coulter, Inc.

Abbott Laboratories

Siemens Healthcare

HORIBA ABX SAS

Mindray

Bio-Rad Laboratories

Nihon Kohden

Abaxis

Market Ecosystem

Raw material/component suppliers — provide critical components

OEMs / manufacturers — design and manufacture haematology analysers

System integrators / EPCs — integrate analysers into larger systems

Distributors / channel partners — distribute products to end users

Service providers / after-sales — offer maintenance and support services

End users / buyers — purchase and use haematology analysers

Regulators/standards bodies — establish standards and guidelines

Recent Industry Insights

Analyst Overview

Table of Contents